Serum soluble CD163 predicts risk of type 2 diabetes in the general population
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Activation of adipose tissue macrophages with concomitant low-grade inflammation is believed to play a central role in the development of type 2 diabetes. We tested whether a new macrophage-derived biomarker, soluble CD163 (sCD163), identifies at-risk individuals before overt disease has developed.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Clinical Chemistry |
Vol/bind | 57 |
Udgave nummer | 2 |
Sider (fra-til) | 291-7 |
Antal sider | 7 |
ISSN | 0009-9147 |
DOI | |
Status | Udgivet - 1 feb. 2011 |
ID: 34151958